Press Releases

Advanced Search
  • May 10, 2001
    DaVita says price of Amgen's Epogen raised 3.9 pct

    Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 Thursday May 10, 6:59 am Eastern Time TORRANCE, Calif., May 10 (Reuters) - DaVita Inc. (NYSE:DVA), an...

  • May 9, 2001
    Amgen Raises EPOGEN Pricing

    DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective May 9, 2001 at 5:01 PM Pacific Time. This pricing...

  • May 6, 2001
    DaVita Inc. Reports 1st Quarter 2001 Results

    DaVita Inc. , today announced results for the quarter ended March 31, 2001. Net earnings for the first quarter were $21.3 million or $0.24 per share. Continental U.S. EBITDA (earnings before...

  • Apr 11, 2001
    DaVita Completes $225 Million Private Offering 9 1/4% Senior Subordinated Notes

    DaVita Inc. , announced today that it has completed the sale of $225 million of its 9 1/4% Senior Subordinated Notes Due 2001 (the "Notes") in a private offering. The Notes mature on April 15,...

  • Apr 6, 2001
    DaVita Inc. Announces Date for Q1 Earnings Release

    To: Members of the Investment Community From: LeAnne Zumwalt, Vice President Re: DaVita Inc. Q1 2001 Earnings Release Date: April 6, 2001 We are planning a conference call to discuss our Q1 2001...

Show 5102550100 per page